712results about How to "Increase dose" patented technology

The present invention generally relates to compositions comprising anesthesia-reversing agents which facilitate or increase the time of awakening or reverse the effects of general anesthesia-induced unconsciousness. In some embodiments, the anesthesia reversing agent can be selected from any or a combination of methylphenidate (MPH), amphetamine, modafinil, amantadine, caffeine, or analogues or derivatives thereof. In some embodiments, compositions comprising at least one or more anesthesia-reversing agents can be used to facilitate awakening from anesthesia without or decreasing occurrence of delirium, and can be used in methods to treat or prevent the symptoms associated with emergence delirium, as well as treat a subject oversedated with general an esthesia. The invention also relates to methods for administering these compositions comprising anesthesia-reversing agents to subjects and for use.

A method of performing radiation therapy includes delivering a therapeutic dose such as X-ray only to a target (e.g., tumor) with continuous broad beam (or in-effect continuous) using arrays of parallel planes of radiation (microbeams / microplanar beams). Microbeams spare normal tissues, and when interlaced at a tumor, form a broad-beam for tumor ablation. Bidirectional interlaced microbeam radiation therapy (BIMRT) uses two orthogonal arrays with inter-beam spacing equal to beam thickness. Multidirectional interlaced MRT (MIMRT) includes irradiations of arrays from several angles, which interleave at the target. Contrast agents, such as tungsten and gold, are administered to preferentially increase the target dose relative to the dose in normal tissue. Lighter elements, such as iodine and gadolinium, are used as scattering agents in conjunction with non-interleaving geometries of array(s) (e.g., unidirectional or cross-fired (intersecting) to generate a broad beam effect only within the target by preferentially increasing the valley dose within the tumor.

A relocatable container inspection device, which is constituted by modularized units, is used for inspecting a container. The device comprises: a first cabin unit including a radiation source for generating a beam of penetration radiation for penetrating the container to be inspected; a second cabin unit including detectors for detecting the beam of penetration radiation penetrating through the container being inspected and producing corresponding radiographic signals, the second cabin unit and the first cabin unit being arranged oppositely in both sides of an inspection passage; a gantry unit bridging the first cabin unit and the second cabin unit to form a portal-shaped frame adapted for straddling the container being inspected; means for moving the frame relative to the container being inspected along the inspection passage, so that the detectors receive the beam of the penetration radiation generated from the radiation resource and passing through the container being inspected, thereby continuously scanning the container and producing the corresponding radiographic signals, wherein the first cabin unit, the second cabin unit and the gantry unit are all individually made as modular units so as to be quickly and easily assembled and disassembled with each other on the inspection site. In the present invention, all of the modularized units of the container inspection device can be easily assembled and disassembled in the work field, and the dimensions of each modular unit are sized to be suitable for road transports and to be facilitate for the device's movement.

A device for imaging an object, such as for breast imaging, includes a gantry frame having mounted thereon an x-ray source, a source grating, a holder or other place for the object to be imaged, a phase grating, an analyzer grating, and an x-ray detector. The device images objects by differential-phase-contrast cone-beam computed tomography. A hybrid system includes sources and detectors for both conventional and differential-phase-contrast computed tomography.

A method of modeling propagation of a pharmaceutical fluid in a patient, includes: collecting data corresponding to a time response curve resulting from injection of the fluid; and determining at least one mathematical model describing the data. The mathematical model can, for example, be a model which is not determined by a continuous or a discrete-time Fourier transform of the data. A method of controlling injection of a pharmaceutical fluid into a patient using an injector in a medical procedure, includes: collecting data corresponding to a patient response curve resulting from injection of the fluid; determining at least one mathematical model describing the data; and controlling the injector during the medical procedure to control injection of the fluid into the patient to create patient response at least in part on the basis of the mathematical model. A method of controlling injection of a contrast medium into a patient using an injector in a medical imaging procedure using an imaging scanner, includes: determining at least one mathematical model to predict a time enhancement response resulting from injection of the contrast medium; determining an injection protocol to approximate a predetermined time enhancement response in the patient by determining a constrained input solution to the mathematical model; and using the injection protocol to control the injector during the medical imaging procedure to control injection of the contrast medium into the patient to create an image of a region of interest.

The present invention provides a system, method and apparatus for treating a liquid by providing a wave energy source and creating a thin film of the liquid whirling around the wave energy source such that one or more wave energies irradiate the liquid. Likewise, the present invention provides a method of treating a liquid by providing three zones of wave energy and passing the liquid through the three zones of wave energy.